|
⚲
|
| Keyboard |
| GT Biopharma Inc | |
|---|---|
| Firm | |
| Fund # | |
| CIK # | 0000109657 |
| Sale | 2026-09-14 (39.0 M Offered, 7.8 M Sold) |
| Fund | |
| Phone | 4159194040 |
| Address | 505 Montgomery Street San Francisco, CA 94111 |
| Source | [EDGAR] |
| Amount Raised ($M) |
|---|
| Company Details | |
|---|---|
| Director | |
| Custodian | |
| Auditor | |
| Marketer | |
| Broker | |
| Jurisdiction |
| Form D Offering | |
|---|---|
| Filed | 2026-09-29 (D) |
| Exemption | 506(b) |
| Remaining | $31,208,054 |
| Duration | More than one year |
| Revenue | Decline to Disclose |
| In the News | |
|---|---|
| Sun, 13 Sep 2026 | GT Biopharma ( NASDAQ : GTBP ) Downgraded to Strong Sell Rating by Wall Street Zen — tickerreport.com |
| Sat, 15 Aug 2026 | GT Biopharma ( NASDAQ : GTBP ) Releases Quarterly Earnings Results , Misses Expectations By $0 . 04 EPS — themarketsdaily.com |
| Tue, 14 Jul 2026 | GT Biopharma ( NASDAQ : GTBP ) Stock Price Down 8 . 8 % – What Next ? — themarketsdaily.com |
| Directors | Role | 2011 - 2026 |
|---|---|---|
| David Mun-Gavin | Director | |
| Hilary Kramer | Director | |
| Charles Casamento | Director | |
| Alan Urban | Executive Officer | |
| Michael Breen | Executive Officer |
| Comparable Firms | State | AUM |
|---|---|---|
|
Institutional Venture Management XVII LLC
✚
|
CA | |
|
The Social Capital Partnership LLC
✚
|
CA | |
|
Otherwise Fund Management LLC
✚
|
CA | |
|
Bullpen Management LLC
✚
|
CA | |
|
Type One Management LLC
✚
|
CA | |
|
Hanabi Capital Management LLC
✚
|
CA | |
|
Liquid 2 Ventures LLC
✚
|
CA | |
|
Canvas Management Company LLC
✚
|
CA | |
|
Good Friends LLC
✚
|
CA | |
|
MNS Global Capital Managers LLC
✚
|
CA |